General Information of Drug (ID: DMQK32F)

Drug Name
5-tert-Butyl-2-(4-fluoro-phenyl)-[1,3]dithiane
Synonyms CHEMBL315953; ZINC584614859; ZINC584614855
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 270.4
Logarithm of the Partition Coefficient (xlogp) 5
Rotatable Bond Count (rotbonds) 2
Hydrogen Bond Donor Count (hbonddonor) 0
Hydrogen Bond Acceptor Count (hbondacc) 3
Chemical Identifiers
Formula
C14H19FS2
IUPAC Name
5-tert-butyl-2-(4-fluorophenyl)-1,3-dithiane
Canonical SMILES
CC(C)(C)C1CSC(SC1)C2=CC=C(C=C2)F
InChI
InChI=1S/C14H19FS2/c1-14(2,3)11-8-16-13(17-9-11)10-4-6-12(15)7-5-10/h4-7,11,13H,8-9H2,1-3H3
InChIKey
MFJQBAHBCVIQEE-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
10015993
TTD ID
D02YGZ

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Gamma-aminobutyric acid receptor (GAR) TTNJYV2 NOUNIPROTAC Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Synthesis of carbon-11-, fluorine-18-, and iodine-125-labeled GABAA-gated chloride ion channel blockers: substituted 5-tert-butyl-2-phenyl-1,3-dith... J Med Chem. 1995 Jul 7;38(14):2663-71.